| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c22c6d06e5563aee18cc3c610cfa6180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_218debc45969aa2940dd86103892c0b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f00091fa98c0af526666d45068910f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb08f40186f16de80cb08ad38be41cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1eacec0b2a4ffdc2950ba8f2d3af9cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2619f149a960e22fb386f4d8a37e2b9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025 |
| filingDate |
2004-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ac7dc9de8ea8e4cfe25b015ed9b290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af325dc0d14679745e4ba12252f3e55e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb82c0bd5c44d5ef222a5d3ac5d763c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_769638718e88f26d21aaf9582b5d7abe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdefce1079f6747c9c46b8af51dce6f2 |
| publicationDate |
2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005032585-A1 |
| titleOfInvention |
Pharmaceutical compositions containing human papilloma virus antigens |
| abstract |
The invention relates to compositions which are used to induce an immune response, preferably cellular, and, in particular, a cytolytic immune response mediated by cells against human papilloma virus (HPV) antigens. One embodiment of the invention relates to compositions containing the protein fusion of a HPV antigen or portions derived therefrom to Neisseria meningitidis porin P1 and the bonding thereof by means of hydrophobic linkages or mixing with very small size proteoliposomes (VSSPs). The invention also relates to a composition containing peptides derived from HPV and the bonding thereof by means of hydrophobic linkages or mixing with VSSPs. The resulting vaccine compositions can be used to induce a cellular immune response against HPV and against cells that present HPV antigens including HPV-associated tumours. The aforementioned compositions are suitable for use in the pharmaceutical industry as vaccines in human therapeutics. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000545-B2 |
| priorityDate |
2003-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |